section name header

Y-Site Injection Compatibility (1:1 Mixture)

Oritavancin diphosphate

(Mfr: TAR)(Conc: 0.8, 1.2, and 2 mg/mLa)

QMark

Sodium bicarbonate

(Mfr: HOS)(Conc: 1 mEq/mLb)

Remarks:

Haze forms immediately but disappears with shaking

Ref:

2928